Prøve GULL - Gratis
Transforming Diagnostics and Personalized Medicine Amidst Challenges
The Business Guardian
|December 29, 2024
Genomic testing, an advanced diagnostic tool, delves deep into the analysis of DNA, RNA, and proteomics to uncover genetic mutations, assess disease risks, and provide critical insights for medical decisions.
The field has seen transformative progress with the advent of technologies like next-generation sequencing, enabling the early detection of diseases, particularly cancers.
This cutting-edge approach has significantly enhanced diagnostic precision, making it a cornerstone in personalized medicine. However, challenges persist. Restricted insurance coverage, high costs, and the complexity of interpreting vast genomic data continue to hinder its widespread adoption.
These obstacles underscore the need for robust frameworks to ensure accessibility and affordability.
To shed light on this evolving field and its implications for healthcare, we turn to Dr. Kirti Chadha, Chief Scientific and Innovation Officer at Metropolis Healthcare Limited.
Q: What is genomic testing, and how does it differ from traditional diagnostic tests?
A: In 2003, the Human Genome Project that mapped an understanding of all human genes was completed and changed the entire testing scope impacting every clinical segment. Although genetic testing started way back in 1950 when Down (trisomy 21) and other syndromes were diagnosed by cytogenetic methods & evolved further in 1990s when the novel technique of PCR accelerated molecular genetic testing by enabling targeted testing for known pathogenic variants, it accelerated only when Next Generation Sequencing & other newer technologies added to the understanding of the human genome and its impact on disease.
Testing has now evolved from comprehensive gene panels to exome and genome sequencing as routine tests, thereby revolutionizing the diagnosis of rare genetic diseases among others.
As compared to traditional lab tests, genomic tests that study DNA, RNA, proteomics can identify mutations in our genes indicating if we have or not a genetic condition while also identifying our risk for developing a certain condition or passing on a genetic disorder to the next generation.
Denne historien er fra December 29, 2024-utgaven av The Business Guardian.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA The Business Guardian
The Business Guardian
Cabinet approves CoalSETU window for auction of coal to boost industrial use and export
Marking another major reform in the coal sector, the Union Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, approved for the Policy for Auction of Coal Linkage for Seamless, Efficient & Transparent Utilisation (CoalSETU) by creation of new window named \"CoalSETU window\" in the NRS Linkage Policy to utilise coal for any industrial use and export.
2 mins
December 13, 2025
The Business Guardian
AI investment surge to accelerate in 2026, offsetting tariff Impact on US economy
Artificial intelligence-related investments are set to accelerate sharply in 2026 as companies expand spending to keep pace with the fast-growing AI revolution, according to a report by Fitch Ratings.
1 mins
December 13, 2025
The Business Guardian
South Korean Intellectual Property Office upgraded to Ministry
Do India need to closely monitor this strategic reorganization move by the government!
3 mins
December 13, 2025
The Business Guardian
APOLLO EXCELCARE HOSPITAL SETS NEW HEART-CARE MILESTONE FOR THE NORTHEAST
Excelcare Hospital, Guwahati, has achieved a major medical milestone by successfully performing the first-ever combined Transcatheter Aortic Valve Implantation (TAVI) and angioplasty in the Northeast.
1 mins
December 13, 2025
The Business Guardian
Insurance Opening: 100% FDI and India's Quest for ‘Insurance for All'
On 12 December the Union Cabinet approved the Insurance Laws (Amendment) Bill, 2025, which proposes raising the foreign direct investment (FDI) cap in insurance companies from 74 % to 100 %.
2 mins
December 13, 2025
The Business Guardian
Piyush Goyal meets New Zealand's Minister of Trade to review FTA talks
Union Minister of Commerce and Industry Piyush Goyal held talks with New Zealand's Minister of Trade and Investment Todd McClay to explore ways to advance negotiations on the proposed Free Trade Agreement (FTA) for the mutual benefit of both countries.
2 mins
December 13, 2025
The Business Guardian
India bets on generative AI to reshape drug discovery, says Union Minister
India will rely on generative AI to accelerate drug discovery and bolster clinical research, Minister of State for Science and Technology Jitendra Singh said on Friday, adding that fears that the technology will replace scientists are unfounded and that AI will only enhance decision-making, not replace experts.
1 min
December 13, 2025
The Business Guardian
ELIMINATING DUST IN CAPITAL IS OUR GOVT'S PRIORITY: CM GUPTA
Delhi Chief Minister Rekha Gupta said on Friday that her government is working on multiple fronts to effectively and sustainably control pollution in the capital.
2 mins
December 13, 2025
The Business Guardian
FED RATE CUT EASES PRESSURE ON RUPEE; INDIA SEEN STABLE ON FX, BONDS: REPORT
The report notes that the Fed’s December policy vote was deeply divided
2 mins
December 13, 2025
The Business Guardian
Shilpkari of Rajasthan: The Art of Traditional Craftsmanship
Shilpkari, or traditional Rajasthani craftsmanship, is a significant part of Rajasthan's rich cultural heritage.
1 mins
December 13, 2025
Listen
Translate
Change font size
